The effect of HDACis combinated with etoposide on osteosarcoma cells
This study was aimed to elucidate its underlying mechanism of synergistic anti-tumour efficacy of HDACis (trichostatin A and nicotinamide) in combination with etoposide (VP16, ETO) on U2OS osteosarcoma cells.